Vaccine Boosts Pancreatic Cancer Survival Rates
A new study published in the journal Nature has found that a personalized mRNA vaccine may reduce the risk of pancreatic cancer returning after surgery. The vaccine, which targets specific immune cells, showed promising results in a small trial of 16 patients, with half experiencing a strong immune response and remaining cancer-free for over three … Read more